Bacterial and viral pathogens have a devastating impact on poultry, shrimp, and livestock production, creating billions of dollars in losses each year. But the main weapons in the fight are antibiotics, which are becoming ineffective as pathogens develop resistance, and are contributing to the global issue of antimicrobial resistance (AMR). The animal production industry is extremely incentivized to find ways to reduce the use of antibiotics and maximize output by improving animal health. NovoBind’s next-generation biologics help to tackle key diseases without the use of antibiotics in a cost neutral manner to the farmer.
Read feature here.
Comments